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Dengue is emerging as the most important mosquito borne viral disease in the world. In mainland China, sporadic
and large outbreaks of dengue illness caused by the four serotypes of dengue virus (DENV-1 to DENV-4) have been
well documented. Guangdong province is the major affected area in China, and DENV-1 has dominantly circulated
in Guangdong for a long time. In this study, a family cluster of DENV-3 infection in Guangzhou was described.
Three cases were diagnosed as dengue fever based on clinical manifestation, serological and RT-PCR assays. Two
DENV-3 strains were isolated in C6/36 cells and the complete genome sequences were determined. Phylogenetic
analysis revealed that the new DENV-3 isolates from the family cluster were grouped within genotype III.
Considering the fact that several DENV-3 strains within genotype V were also identified in Guangzhou in 2009, at
least two genotypes of DENV-3 co-circulated in Guangzhou. Careful investigation and virological analysis should be
warranted in the future.
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Dengue is increasing in both frequency and magnitude
worldwide, posing a heavy public health and economic
burden especially in tropical and subtropical countries.
Today, dengue ranks as the most important mosquito-
borne viral disease in the world. Annually, up to 50 mil-
lion human infections occur with 22, 000 deaths mainly
in children [1]. Even, population growth, urbanization,
international travel, and global warming continuously
enhance vector transmission and disease outbreaks [2].
Dengue virus (DENV) contains four serotypes, and each
of them can cause a wide spectrum of clinical manifesta-
tions, including mild dengue fever (DF), severe dengue
haemorrhagic fever (DHF) and deadly dengue shock syn-
drome (DSS). Although intensive efforts have been made
for decades, no preventive vaccines or antiviral drugs
is currently available. The pathogenesis of DHF and* Correspondence: qincf@bmi.ac.cn; zfc8y@yahoo.com.cn
†Equal contributors
1State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of
Microbiology and Epidemiology, No.20 Dongda Street, Fengtai District,
Beijing 100071, China
2Guangzhou No.8 People’s Hospital, Guangzhou Medical College, Guangzhou
510060, China
Full list of author information is available at the end of the article
© 2012 Jiang et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the orDSS remains poorly understood. However, secondary
infection with another DENV serotypes clearly in-
creased the risk of severe diseases via the mechanism
of antibody dependent enhancement (ADE) [3-5]. Epi-
demiological and in vivo data also indicated that anti-
DENV antibodies mediated pathogenesis of a second
heterotypic DENV infection [6-8].
Mainland China has experienced large outbreaks of DF
during World War II, after that dengue disappeared for
about 30 years. Since 1978, mainland China has seen a re-
surgence of dengue, epidemics involving hundreds of
thousands of people have occurred in many provinces of
Southern China, including Hainan, Guangdong, Guangxi,
Fujian, Yunnan and Zhejiang provinces [9-14]. Currently,
DF is listed as the notifiable infectious disease by the Min-
istry of Health, China. The recent epidemiology of dengue
in China is characterized by a 3–5 year cycle. Most cases
are DF, and only a few DHF or DSS cases have been
reported over the last decade in mainland China [9,10,13].
In dengue endemic country, the presence of four sero-
types of DENV is common, and co-circulation of mul-
tiple dengue serotypes in the same area has been well
documented [15-17]. Guangdong province has been
recognized as the major affected area of China. Althoughtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Primers used for sequencing reactions
Primer
Name
Locationa Sequence (5'-3') Product
(bp)
F1 1-22 AGTTGTTAGTCTACGTGGACCG 1054
R1 1036-1054 CGTGGGCTTGTTCTTAGCC
F2 857-877 GCCCATTACATAGGCACTTCC 1199
R2 2036-2055 CTTTCCCCAAAAGGAGGTTC
F3 1946-1965 GAGGATGGACAAGGGAAAGC 1403
R3 3326-3348 CACCATTCGTGTATCAACTTCCC
F4 3224-3245 GGAAAATTGGAGCTGGACTTCA 1001
R4 4206-4224 GCCACTAATGGTCCAGCCA
F5 4112-4131 CTCAAAAGGAGAAGCTGGCC 1208
R5 5299-5319 CGCATTGTGAACGTTGCGTG
F6 5252-5274 GCAACAAAATCTGAACACACAGG 1071
R6 6301-6321 GAATAAGTGCGGGCATCAAGC
F7 6059-6077 AAGTCAGCCGCCATAGACG 1389
R7 7428-7447 AGGTGATCCTTCCCAGAGTG
F8 7032-7049 AGGCAGTGGTCCTGATGG 1143
R8 8153-8174 GCATTCCTCCATGTTTCCTTTG
F9 8015-8032 TCACCAAGCCCAACAGTG 1528
R9 9520-9542 TGGCCATTCTTTTTAACCTCTCC
F10 9270-9293 AGCTCACATACCAAAACAAAGTGG 1060
R10 10299-10318 AGCTTCTTCCGTACTGTGGC








a Primer location refers to DENV-3 strain 80–2 [GenBank: AF317645].
b Primer F11 was also used as 3’RACE primer.
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the dominant serotype circulating in Guangdong is
DENV-1, no other serotypes has been recorded since
2001 [9,10,13,18]. Large DF outbreaks involving more
than 1000 cases caused by DENV-1 have been described
in Guangdong, China in 2002 and 2006, respectively
[13,19].
In this study, we sought to determine the cause of a
family cluster of DF in Guangzhou, Guangdong prov-
ince, China in 2009, and analyze the possible origin of
these emerging isolates responsible for the epidemic.
Materials and methods
Case description
On Aug 6, 2009, three adult family members admitted
to Guangzhou No.8 People’s Hospital as suspected DF
cases. The 30-year-old son firstly had a sudden fever
with headache, then his father (56-year-old) and mother
(50-year-old) fell ill subsequently in the following two
days. All the three cases developed typical DF symptoms,
including fever, headache, chills, rash, muscle and joint
pain, and anorexia. The couples developed diarrhoea,
and none of them showed vomiting. The tourniquet
tests were all positive. All patients recovered unevent-
fully and discharged on Aug 11, 2009.
Ethics statement
The research was approved by the Review Board of
Guangzhou No.8 People’s Hospital and the Ethical Com-
mittee of State Key Laboratory of Pathogen and Biose-
curity. Informed consent was obtained from patients.
Serological assay and RT-PCR
Acute phrase sera were subjected to serological assays
using IgM and IgG capture ELISA kit (PanBio, Queensland,
Australia) according to the manufacturer’s instruction. RT-
PCR assays were performed to detect and typing of DENVs
as previously described [20].
Virus isolation and identification
Acute phase sera from the three patients were inocu-
lated in C6/36 mosquito cells (Aedesalbopitus clone) and
maintained in 1640 medium (Life Technologies, CA,
USA) supplement with 2% fetal bovine serum (Life
Technologies) at 28 °C in 5% CO2. When complete cyto-
pathic effects (CPE) were observed, culture supernatants
from positive samples were collected and stored at −70 °C
until use. Indirect immunofluscence assay (IFA) was per-
formed as previously described [21].
Sequencing of complete genome of DENV-3 isolates
The viral RNA was extracted from 200 μl of DENV-3
infected C6/36 culture supernatant using Purelink RNA
mini kit (Life Technologies) in accordance with themanufacturer’s instructions. A total of 11 overlapping
amplicons spanning the complete genomic region were
amplified using 11 pairs of primers. The PCR products
were sequenced and assembled. The 5’ and 3’ untrans-
lated regions (UTRs) of viral genome of each isolate
were determined using a rapid amplification of either 5’
or 3’ cDNA ends (RACE) kit (Roche, Mannheim, Ger-
many) followed the manufacturer’s recommendation. All
primers can be found in Table 1.Sequence alignment and phylogenetic analysis
The complete nucleotide sequences of the complete
sequences of coding region or envelope (E) gene of glo-
bal DENV-3 strains were retrieved from GenBank
(Table 2). Multiple sequence alignment was carried out
employing the CLUSTAL W program [22]. Phylogenetic
analyses based on the nucleotide sequence of complete
coding region of 44 DENV-3 or complete envelope gene
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ND143 2007 India FJ644564 III
DEL-72 2008 India GQ466079 III
DENV-3/LK/
BID-V2405
1983 Sri Lanka GQ199887 III
DENV-3/LK/
BID-V2409
1997 Sri Lanka GQ252674 III
DENV-3/MX/
BID-V2989
2007 Mexico FJ898442 III
DENV-3/US/
BID-V2103
2000 USA FJ547071 III
DENV-3/US/
BID-V1080
2006 USA EU529699 III
DENV-3/US/
BID-V1620
2005 USA FJ182010 III
DENV-3/US/
BID-V1090
1998 USA EU529703 III
DENV-3/US/
BID-V1043
2006 USA EU482555 III




2000 Venezuela FJ639750 III
DENV-3/VE/
BID-V2481
2007 Venezuela GQ868586 III
DENV-3/NI/
BID-V2419
1998 Nicaragua GQ199886 III
DENV-3/NI/
BID-V2420
1994 Nicaragua FJ882576 III
DENV-3/NI/
BID-V2649
2008 Nicaragua FJ873813 III
DENV-3/NI/
BID-V4761
2009 Nicaragua HM181972 III
DENV-3/NI/
BID-V3055
2008 Nicaragua GQ199860 III
DENV-3/NI/
BID-V5498
2010 Nicaragua JF937633 III
DENV-3/LC/
BID-V3929
2001 Saint Lucia GQ868616 III
DENV-3/BR/
BID-V2400
2007 Brazil FJ850092 III
DENV-3/BR/
BID-V2977
2001 Brazil FJ898446 III
DENV-3/BR/
BID-V3606
2007 Brazil GU131876 III
DENV-3/IPC/
BID-V3832
2007 Cambodia GU131917 II
DENV-3/KH/
BID-V2082
2003 Cambodia FJ639725 II
DENV-3/IPC/
BID-V3820
2006 Cambodia GU131908 II
DENV-3/IPC/
BID-V4286
2007 Cambodia GU131937 II
DENV-3/KH/
BID-V2080
2003 Cambodia FJ639723 II
DENV-3/VN/
BID-V1013
2006 Viet Nam EU482457 II
DENV-3/VN/
BID-V1911
2008 Viet Nam FJ547066 II
C0360/94 1994 Thailand AY923865 II
C0331/94 1994 Thailand AY876494 II
DENV-3/TH/
BID-V2315
2001 Thailand FJ744729 II
DENV-3/TH/
BID-V3360







den3-88 1988 Indonesia AY858038 I
FW01 2004 Indonesia AY858040 I
H87 1956 Philippines M93130 V
BS-PRico63 1963 Puerto Rico AY146762 IV
1339 1977 Puerto Rico AY146761 IV
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Figure 1 (See legend on next page.)
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Figure 1 Phylogenetic tree based on the complete envelope gene from 58 DENV-3 strains sampled globally. The evolutionary history
was inferred using the neighbor-joining method with MEGA 5 software [24]. Each strain is abbreviated with strain name and country of origin
followed by the year of isolation. Bootstrap values greater than 0.9 based on 1000 replicates are shown for key nodes. The tree was rooted using
DENV-1 strain Nauru, DENV-2 strain New Guinea C and DENV-4 strain B5 as outgroups. The newly DENV-3 isolates in the study are marked with
red squares and other Chinese DENV-3 isolates taken for comparison are marked with blue squares.
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http://www.virologyj.com/content/9/1/125of 58 DENV-3 were carried out by Neighbor-Joining
method using MEGA version 5.05 or by Bayesian method
using BEAST version 1.7.1 [23,24]. The Neighbor-Joining
trees were constructed by Tamura-Nei model with gamma-
distribution of among-site [25]. The Bayesian trees were in-
ferred by Markov Chain Monte Carlo (MCMC) for
5,000,000 generations, sampling at every 100 the genera-
tions. Sequences of the DENV-1 strain WestPac [GenBank:
U88535], DENV-2 strain NGC [GenBank: AF038403] and
DENV-4 strain B5 [GenBank: AF289029] were used as
outgroups.Results
All three family members were diagnosed as DF accord-
ing to the new guideline of World Health Organization
[26]. Laboratory tests disclosed low WBC and lympho-
cytes counts for all the three cases. Normal platelet
counts were recorded for two cases, while that of the
mother was low. None of the patients presented plasma
leakage, severe bleeding, or severe organ involvement.
All cases recovered in a week post admission.
The acute phase sera from all the three family mem-
bers were positive for dengue IgM antibody, but negative
for IgG antibody. Two of the three cases were positive
for DENV-specific RT-PCR. DNA sequencing of the
PCR products and blast analysis revealed closely hom-
ologous with DENV-3. Considering the fact that DENV-
3 has not been described in Guangdong for many years,
all the three samples were inoculated into C6/36 cells to
isolate the viruses. Typical CPE were observed six or
seven days post inoculation for two of three samples.
After another passage in C6/36 cells, two strains were
isolated and named with GZ1D3 and GZ2D3, respect-
ively. Both strains were further confirmed by IFA using
dengue specific monoclonal antibody.
Finally, the complete genome sequences of the isolates
were determined, assembled and submitted to GenBank
[GenBank: GU363549; JN662391]. Both strains were
highly homologous (99.9%) with only three nucleotide
differences. Phylogenetic analysis based on the complete
envelope gene classified DENV-3 isolates into five geno-
types (Figure 1), which was confirmed by the Bayesian
method (Additional file 1: Figure S1). Phylogenetic tree
based on the complete sequence of coding region of
DENV-3 genome showed the same genotype classifica-
tion (Figure 2). The newly isolated DENV-3 strainsbelong to the genotype III, clustering with other DENV-
3 isolates circulating in China in 2009 and in India in
2007 and 2008 (Figure 1). Interestingly, three additional
DENV-3 strains isolated in Guangzhou in 2009 (09/GZ/
1081, 09GZ/1483 and 09/GZ/10806) [27] belong to geno-
type V (Figure 1 & Additional file 1: Figure S1), which indi-
cated that two genotypes of DENV-3 were co-circulating in
Guangdong, 2009.Discussion
In the present study, a family cluster of DENV-3 infec-
tions in Guangzhou, China was described. Three family
members were diagnosed as DF, and all recovered finally.
All the three family members recalled mosquito biting
before illness, and none of them went aboard or on trip
recently. Although family cluster of vector-borne dis-
eases have been intensively described [28,29], informa-
tion regarding DF family cluster is limited. There is no
doubt that any cluster of cases is of great concern and
should be thoroughly investigated. Dengue can cause
both the large epidemics and sporadic infections. The
recognition of clustering of disease is important for
medical providers and public health personnel in treat-
ing and controlling the disease, because multiple infec-
tions can occur simultaneously or following an index
case. In this study, strict mosquito control measures
were initiated immediately after confirmation of the DF
cases, and no further cases were reported nearby
thereafter.
Whether dengue is endemic in Guangdong remains
disputable. Most dengue epidemics in Guangdong were
initiated by the introduction of virus from imported
cases [13,18,19,27,30], however, in this study none of the
family member travelled aboard. Further epidemiology
investigation also did not identify imported case nearby
either. The origin of these DENV-3 isolate is really inter-
esting. Since DENV-1 has circulated in Guangzhou for
about ten years, the new DENV-3 has potential to in-
crease the rate of secondary heterotypic infection. Fur-
thermore, the previous studies showed that epidemic
DHF has appeared in association with DENV-3 [31-33].
In the Americas, DENV-3 presented greater epidemic
potential and virulence [20]. Whatever, the emerging
DENV-3 in Guangzhou might represent a risk factor for
severe dengue illness, careful investigation and surveil-
lance should be warranted in the future.
Figure 2 (See legend on next page.)
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Figure 2 Phylogenetic tree based on complete sequences of coding region of viral genome from 44 DENV-3 strains sampled globally.
The evolutionary history was inferred using the neighbor-joining method with MEGA 5 software [24]. Bootstrap values greater than 0.9 based on
1000 replicates are shown for key nodes. The tree was rooted using DENV-1 strain Nauru, DENV-2 strain New Guinea C and DENV-4 strain B5 as
outgroups. The newly DENV-3 isolates in the study are marked with red squares and other Chinese DENV-3 isolates taken for comparison are
marked with blue squares.
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http://www.virologyj.com/content/9/1/125Most importantly, phylogenetic analysis demonstrated
that at least two different genotypes of DENV-3 were co-
circulated in Guangdong, China in 2009, which partly agree
with the findings of the previous study [27]. Five genotypes
of DENV-3 have been reported [20,34]. The newly isolates
in Guangdong form a distinct cluster with other Chinese
isolates sampled from Zhejiang province in 2009 [35]. All
these genotype III DENV-3 strains were closely related to
those sampled in India in 2007 and 2008, suggesting these
Chinese isolates might be imported from India. Previously,
the introduction of new genotype III of DENV-3 has been
recognized as one of the factors leading to the emergence
of DHF in Pakistan and India [33,36]. These strains are
therefore interesting and their virological characterization
and virulence analyses are currently underway.
However, three additional DENV-3 strains (09/GZ/1081,
09GZ/1483, and 09/GZ/10806), belonging to genotype V,
were also identified in Guangzhou, 2009 in a separate study
[27]. In addition, two strains (07CSHL001 and DTID-
ZJU04) sampled from China, were grouped within geno-
type II. The origin of these isolates is difficult to determine
without further information. The situation that multiple
genotypes of DENV-3 co-circulated in Guangzhou, China
deserves close concern and careful investigation.
Additional file
Additional file 1: Figure S1. Phylogenetic tree based on the complete
envelope gene from 58 DENV-3 strains by Bayesian method. The
evolutionary history was inferred using BEAST 1.7.1 software. The tree was
rooted using DENV-1 strain Nauru, DENV-2 strain New Guinea C and
DENV-4 strain B5 as outgroups. The newly DENV-3 isolates in the study
are marked with red squares and other Chinese DENV-3 isolates taken for
comparison are marked with blue squares.
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